Ranjit Deshmukh Email

VP, Manufacturing and Supply . Ocugen

Malvern, PA

Location

LinkedIn

Current Roles

Employees:
120
Revenue:
$18.6M
About
Ocugen Inc. (NASDAQ: OCGN) is a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure blindness diseases. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug – “one to many” and our novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy.
Ocugen Address
11 Great Valley Parkway
Malvern, PA
United States
Ocugen Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.